self-inhibited structure of full-length PCSK9 at 1.9 Å reveals structural homology with resistin within the C-terminal domain

Mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9) are strongly associated with levels of low-density lipoprotein cholesterol in the blood plasma and, thereby, occurrence or resistance to atherosclerosis and coronary heart disease. Despite this importance, relatively little is known...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 104; no. 37; pp. 14604 - 14609
Main Authors Hampton, Eric N, Knuth, Mark W, Li, Jun, Harris, Jennifer L, Lesley, Scott A, Spraggon, Glen
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 11.09.2007
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9) are strongly associated with levels of low-density lipoprotein cholesterol in the blood plasma and, thereby, occurrence or resistance to atherosclerosis and coronary heart disease. Despite this importance, relatively little is known about the biology of PCSK9. Here, the crystal structure of a full-length construct of PCSK9 solved to 1.9-Å resolution is presented. The structure contains a fully folded C-terminal cysteine-rich domain (CRD), showing a distinct structural similarity to the resistin homotrimer, a small cytokine associated with obesity and diabetes. This structural relationship between the CRD of PCSK9 and the resistin family is not observed in primary sequence comparisons and strongly suggests a distant evolutionary link between the two molecules. This three-dimensional homology provides insight into the function of PCSK9 at the molecular level and will help to dissect the link between PCSK9 and CHD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by James A. Wells, University of California, San Francisco, CA, and approved July 25, 2007
Author contributions: E.N.H., M.W.K., J.L., J.L.H., S.A.L., and G.S. designed research; E.N.H., M.W.K., and G.S. performed research; E.N.H., J.L., and G.S. analyzed data; and J.L., J.L.H., S.A.L., and G.S. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0703402104